These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 34901156)

  • 1. Bioinformatic Analyses and Experimental Verification Reveal that High FSTL3 Expression Promotes EMT
    Liu Y; Li J; Zeng S; Zhang Y; Zhang Y; Jin Z; Liu S; Zou X
    Front Mol Biosci; 2021; 8():762924. PubMed ID: 34901156
    [No Abstract]   [Full Text] [Related]  

  • 2. Follistatin-Like 3 Correlates With Lymph Node Metastasis and Serves as a Biomarker of Extracellular Matrix Remodeling in Colorectal Cancer.
    Yang C; Cao F; Huang S; Zheng Y
    Front Immunol; 2021; 12():717505. PubMed ID: 34335633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cytoplasmic expression of FSTL3 correlates with colorectal cancer progression, metastasis status and prognosis.
    Li CH; Fang CY; Chan MH; Chen CL; Chang YC; Hsiao M
    J Cell Mol Med; 2023 Mar; 27(5):672-686. PubMed ID: 36807490
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Liu YJ; Li JP; Zhang Y; Nie MJ; Zhang YH; Liu SL; Zou X
    Onco Targets Ther; 2021; 14():4099-4117. PubMed ID: 34262295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Follistatin-Like 3 Enhances Invasion and Metastasis via β-Catenin-Mediated EMT and Aerobic Glycolysis in Colorectal Cancer.
    Li Y; Tian M; Liu W; Wang D; Zhou Z; Pei Q; Huang Y; Tan F; Güngör C
    Front Cell Dev Biol; 2021; 9():660159. PubMed ID: 34395416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FSTL3 promotes tumor immune evasion and attenuates response to anti-PD1 therapy by stabilizing c-Myc in colorectal cancer.
    Li H; Zheng N; Guo A; Tang W; Li M; Cao Y; Ma X; Cao H; Ma Y; Wang H; Zhao S
    Cell Death Dis; 2024 Feb; 15(2):107. PubMed ID: 38302412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Follistatin-like 3 suppresses cell proliferation and fibronectin expression via p38MAPK pathway in rat mesangial cells cultured under high glucose.
    Wang X; Shi L; Han Z; Liu B
    Int J Clin Exp Med; 2015; 8(9):15214-21. PubMed ID: 26629006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of follistatin-like 3 in human invasive breast cancer.
    Couto HL; Buzelin MA; Toppa NH; Bloise E; Wainstein AJ; Reis FM
    Oncotarget; 2017 Jun; 8(26):42189-42197. PubMed ID: 28178680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Impact of FSTL3, ADAM12, and FAT4 in Patients of Colon Cancer: Clinicopathologic Study.
    Ibrahim HM; Abdelrahman AE; Elwan A; Bakry A; Fahmy MM; Abdelhamid MI; Abdelwanis AH; Fouad EM
    Appl Immunohistochem Mol Morphol; 2023 Nov-Dec 01; 31(10):673-681. PubMed ID: 37751246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HBXIP: a potential prognosis biomarker of colorectal cancer which promotes invasion and migration via epithelial-mesenchymal transition.
    Wang X; Feng Q; Yu H; Zhou X; Shan C; Zhang Q; Liu S
    Life Sci; 2020 Mar; 245():117354. PubMed ID: 31987874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis.
    Wei C; Yang C; Wang S; Shi D; Zhang C; Lin X; Liu Q; Dou R; Xiong B
    Mol Cancer; 2019 Mar; 18(1):64. PubMed ID: 30927925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of NREP Promotes Migration and Invasion in Gastric Cancer Through Facilitating Epithelial-Mesenchymal Transition.
    Liu YJ; Zeng SH; Hu YD; Zhang YH; Li JP
    Front Cell Dev Biol; 2021; 9():746194. PubMed ID: 34746143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-302c represses epithelial-mesenchymal transition and metastasis by targeting transcription factor AP-4 in colorectal cancer.
    Ma W; Liu B; Li J; Jiang J; Zhou R; Huang L; Li X; He X; Zhou Q
    Biomed Pharmacother; 2018 Sep; 105():670-676. PubMed ID: 29906744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High SEMA4C expression promotes the epithelial-mesenchymal transition and predicts poor prognosis in colorectal carcinoma.
    Hou Y; Wang W; Zeng Z; Gan W; Lv S; Li T; Yan Z; Zhang R; Yang M
    Aging (Albany NY); 2020 Nov; 12(21):21992-22018. PubMed ID: 33177246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-4775 promotes colorectal cancer invasion and metastasis via the Smad7/TGFβ-mediated epithelial to mesenchymal transition.
    Zhao S; Sun H; Jiang W; Mi Y; Zhang D; Wen Y; Cheng D; Tang H; Wu S; Yu Y; Liu X; Cui W; Zhang M; Sun X; Zhou Z; Peng Z; Yan D
    Mol Cancer; 2017 Jan; 16(1):12. PubMed ID: 28095858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA RPPH1 promotes colorectal cancer metastasis by interacting with TUBB3 and by promoting exosomes-mediated macrophage M2 polarization.
    Liang ZX; Liu HS; Wang FW; Xiong L; Zhou C; Hu T; He XW; Wu XJ; Xie D; Wu XR; Lan P
    Cell Death Dis; 2019 Nov; 10(11):829. PubMed ID: 31685807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. THBS1 facilitates colorectal liver metastasis through enhancing epithelial-mesenchymal transition.
    Liu X; Xu D; Liu Z; Li Y; Zhang C; Gong Y; Jiang Y; Xing B
    Clin Transl Oncol; 2020 Oct; 22(10):1730-1740. PubMed ID: 32052380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The long non-coding RNA TUG1 indicates a poor prognosis for colorectal cancer and promotes metastasis by affecting epithelial-mesenchymal transition.
    Sun J; Ding C; Yang Z; Liu T; Zhang X; Zhao C; Wang J
    J Transl Med; 2016 Feb; 14():42. PubMed ID: 26856330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FLNA promotes chemoresistance of colorectal cancer through inducing epithelial-mesenchymal transition and smad2 signaling pathway.
    Cheng M; Jiang Y; Yang H; Zhao D; Li L; Liu X
    Am J Cancer Res; 2020; 10(2):403-423. PubMed ID: 32195017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA SNHG6 promotes proliferation, invasion and migration in colorectal cancer cells by activating TGF-β/Smad signaling pathway via targeting UPF1 and inducing EMT via regulation of ZEB1.
    Wang X; Lai Q; He J; Li Q; Ding J; Lan Z; Gu C; Yan Q; Fang Y; Zhao X; Liu S
    Int J Med Sci; 2019; 16(1):51-59. PubMed ID: 30662328
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.